Kathua to become India’s antibiotic powerhouse with ₹600 crore pharma facility

This state-of-the-art facility will specialise in producing Amino Cephalosporanic Acid, a vital component of antibiotics. With this investment, India is set to bolster its pharmaceutical sector and lessen dependence on foreign imports.Read More